Vertical Longevity Pharma
A senolytic therapy to reverse atherosclerosis and extend healthy lifespan, targeting aging at its root with scalable, low-cost immunotherapy.
🧬 Pharmaceuticals & Drug Development
🧬 Pharmaceuticals & Drug Development
closed January 17, 2026
closed
closed January 17, 2026
closed
Invested$40,427.66
oversubscribed404%
Funding goal$10K
Minimum ticket$99.91
Investors-
Terms
Sign in to view terms
Funding ProgressProgress
Executive Summary
We work hard to provide accurate data.Found something incorrect? Let us know and we'll fix it.
Investor Perks
No investor perks availableThis may not apply to this offering or may not be available yet. If we receive this information, it will appear here.
Investor Discussion Brief
No investor discussion availableThis may not apply to this offering or may not be available yet. If we receive this information, it will appear here.
Regulatory Filings
No regulatory filings availableThis may not apply to this offering or may not be available yet. If we receive this information, it will appear here.
Unlock Full Campaign DetailsCreate a free account to access comprehensive investment data and make informed decisions.
Funding History
Financials
Investor Perks
Timeline
Team Members
Offering Terms